By Ollie Potter | Last updated: April 2026 | 9 min read

Cellular agriculture startups raised $3.1 billion cumulatively by 2023, targeting a $700 billion global meat market. The sector peaked at $1.4 billion in 2021. Then investors realized scalability and cost parity would take longer than VC timelines allow. Now the survivors are separating from the casualties. Industry analysts predict 70 to 90% of current players will fail within a year.

The companies still standing have either secured regulatory approval, slashed production costs by double digits, or pivoted to adjacent markets. The rest are running out of runway.

If you're watching one company, watch Upside Foods. They raised more than the next three competitors combined. They secured the first FDA safety clearance in US history. They opened a production facility while peers like SCiFi Foods folded. Regulatory approval matters more than technology when the market is this young. Upside has it.

The first FDA-cleared cultivated meat in US history, backed by Tyson Foods and Bill Gates.

Founded: 2015 | HQ: Berkeley, California | Funding: $580.8M

Upside Foods (formerly Memphis Meats) raised more capital than any other cellular agriculture startup. Their $400M Series C, led by Lux Capital, came from Cargill, Tyson Foods, Bill Gates, and Richard Branson. That investor list tells you everything. The meat industry is hedging its bets.

They secured FDA safety clearance in November 2022, becoming the first cultivated meat company approved in the United States. While competitors burned through capital on R&D, Upside opened a production facility in California and started preparing for commercial launch.

The company's competitive advantage isn't just technology. It's regulatory momentum. In a sector where approval timelines kill startups, Upside crossed the finish line first.

Cut production costs 97% while its biggest competitor folded.

Founded: 2017 | HQ: Rehovot, Israel | Funding: $140M+

Aleph Farms makes whole-cut ribeye steaks, not ground meat. That distinction matters. Most cultivated meat companies produce mince because it's easier. Aleph grows actual steak cuts with marbling and texture.

They've reduced production costs 97% since 2020, a milestone competitors haven't matched. Their Series B raised $105M from L Catterton and DisruptAD in 2021. By 2024, they were struggling to close a $29M round. They eventually secured it with $10M to $15M still outstanding.

The company underwent a 30% workforce reduction in 2024 as the funding environment collapsed. But they're still standing. They received approval to sell in Israel in 2024 and partnered with chef Eyal Shani for a restaurant launch.

Here's the surprising bit: Aleph produced cultivated meat on the International Space Station in 2019. If you can grow steak in zero gravity, Earth should be straightforward.

The only company actually selling cultivated meat at commercial scale.

Founded: 2011 | HQ: Alameda, California | Funding: $220M+

Eat Just operates Good Meat, the world's first commercially approved cultivated meat product. Singapore granted approval in 2020. Every other company is still chasing regulatory clearance while Good Meat serves chicken in restaurants.

They raised $200M from Temasek in 2021 and invested $120M in a Singapore production facility in 2024. That's not R&D spending. That's manufacturing infrastructure. The company is building for scale while competitors are still in pilot phase.

Good Meat's first-mover advantage compounds daily. Every month they operate commercially, they learn what works at scale. Competitors are still guessing.

The parent company, Just, Inc., also produces plant-based egg products. This gives them diversified revenue while cultivated meat scales. That's a hedge most pure-play startups don't have.

Created the world's first lab-grown burger, funded by Sergey Brin.

Founded: 2013 | HQ: Maastricht, Netherlands | Funding: $119.8M

Mosa Meat made history in 2013 when Dr. Mark Post unveiled a lab-grown hamburger that cost $330,000 to produce. Google co-founder Sergey Brin funded it. That burger proved the concept was possible, even if economics were absurd.

Thirteen years later, Mosa raised $43M in April 2024, one of only two notable rounds that year. They opened two pilot plants in January 2025 and secured EU Horizon 2020 grant funding.

Mosa's backers include Blue Horizon, Bell Food Group, and Merck's M Ventures. The company focuses on cultivated beef burgers, targeting the mass market rather than premium cuts. If cellular agriculture reaches price parity, it'll likely happen with ground meat first.

Dr. Post's academic credibility gives Mosa scientific legitimacy competitors lack. That matters when regulators evaluate safety.

Raised $11M in 2024 with 40 investors while competitors folded.

Founded: 2017 | HQ: San Diego, California | Funding: $129M

BlueNalu makes cell-cultivated bluefin tuna toro, targeting sushi restaurants and fine dining. That's a smart wedge. Premium seafood commands high prices, making early economics viable. Bluefin tuna sells for hundreds per pound. Ground beef doesn't.

They secured $11M in 2024 from roughly 40 investors, a sign of broad support even in a brutal funding environment. Their Series B raised $33.5M in November 2023. Earlier rounds totaled $60M in convertible notes.

BlueNalu's product is mercury-free and pollutant-free, addressing real concerns with wild-caught tuna. The company operates a pilot facility in San Diego, the historic tuna capital of the US. CEO Lou Cooperhouse founded the company in Hawaii, inspired by Pacific Ocean conservation, before relocating to California.

Strategic partnerships with Thai Union and Rich Products Corporation give BlueNalu distribution channels most startups lack. They're building toward commercial launch, pending US regulatory approval.

Backed by Jeff Bezos and Leonardo DiCaprio for sushi-grade salmon.

Founded: 2016 | HQ: San Francisco, California | Funding: $119.5M

Wildtype raised a $100M Series B in 2024, led by Khosla Ventures. Bezos Expeditions and Leonardo DiCaprio co-invested. When the founder of Amazon and an A-list climate activist both write checks, the pitch is compelling.

The company makes cell-cultivated salmon for sushi. Like BlueNalu, they're targeting premium seafood where margins support early-stage economics. Sushi-grade salmon sells for $20 to $30 per pound retail. That's a different business model than $5-per-pound chicken.

Wildtype unveiled their first salmon tasting in 2020. By 2024, they'd raised more than most cultivated meat companies. The seafood angle differentiates them from the crowded beef and chicken space.

Sustainable seafood is a $150 billion market with real supply constraints. Wild salmon populations are declining. Farmed salmon has environmental issues. Wildtype offers a third option.

Cut costs 90% and pivoted to skincare while competitors burned cash.

Founded: 2018 | HQ: Hong Kong | Funding: $10.8M

Avant (formerly Avant Meats) started with cultivated fish but made a smart pivot. They commercialized Zellulin, a cell-based skincare ingredient, in 2021 while continuing fish development. That dual approach generates revenue today while cultivated meat scales.

The company achieved a 90% cost reduction by March 2021, faster than most competitors. Their Series A raised $10.8M in July 2022, with backing from S2G Investments and Vinh Hoan, the world's largest fish exporter.

That Vinh Hoan partnership matters. If you're building cultivated fish, having the dominant global fish exporter as a strategic investor gives you manufacturing expertise and distribution channels. Avant announced R&D and pilot facilities in Singapore in April 2021 but transitioned operations out of Singapore in 2024 to support the industry differently.

The World Economic Forum named Avant a Technology Pioneer in June 2021. They're the leading cellular agriculture company in China and Hong Kong, a massive market Western startups struggle to access.

Makes protein from CO₂ in hours, not months, using NASA technology.

Founded: 2019 | HQ: San Leandro, California | Funding: $75M

Air Protein isn't traditional cellular agriculture. They use precision fermentation to convert CO₂, water, and renewable energy into protein. The technology comes from 1960s NASA research on feeding astronauts during long space missions.

They raised $75M in June 2023, with earlier rounds totaling $32M from ADM Ventures, Barclays, and Google Ventures. ADM's involvement signals interest from the agricultural commodities giant.

Air Protein's process is carbon-negative and produces protein exponentially faster than conventional agriculture. Hours instead of months. No land, no water, no pesticides. The company was named America's Top FoodTech Company in 2024.

Their AirFermentation technology enables year-round production anywhere, eliminating supply chain constraints. If you can make protein from air, you don't need farms. That's the pitch. Whether it scales economically remains the question.

Secured Series B funding in 2024 while most competitors failed.

Founded: 2018 | HQ: Delft, Netherlands | Funding: $82M

Meatable raised a $35M Series B in 2024, one of only two notable rounds that year. Their Series A brought in $47M in 2021. Total funding: $82M.

The company makes cultivated pork and beef, backed by DSM (now DSM-Firmenich), a major ingredients corporation, and BlueYard Capital. They opened two pilot plants in January 2025, moving from R&D to production.

Meatable's ability to raise in 2024 signals investor confidence. Most cellular agriculture startups couldn't close rounds. The ones that did, like Meatable and Mosa Meat, have credible paths to commercialization.

The Netherlands is becoming a cellular agriculture hub, with Mosa Meat and Meatable both headquartered there. Regulatory support and scientific infrastructure make it attractive.

Growing cocoa without trees, backed by Japan's largest chocolate maker.

Founded: 2019 | HQ: Davis, California | Funding: $4M+

California Cultured makes cell-cultured cocoa, addressing deforestation and child labor in chocolate production. They use plant cell culture to grow cocoa without cacao trees, producing chocolate, cocoa powder, cocoa butter, and flavanols.

They raised $4M in seed funding led by Agronomics and partnered with Meiji Co. Ltd, Japan's largest chocolate manufacturer. Barry Callebaut, the world's leading cocoa processor, is exploring their technology. Those partnerships validate the approach.

California Cultured filed a patent on cocoa butter via plant cell culture in September 2025. They plan to launch a direct-to-consumer subscription model, targeting premium chocolate buyers willing to pay for sustainable sourcing.

The company uses $3,000 reusable plastic bioreactors and food-grade ingredients (no herbicides) to stimulate cocoa cell growth. CEO Alan Perlstein is a second-time founder after Joywell Foods. He knows how to commercialize novel food ingredients.

The sector is consolidating around companies with regulatory approval, proven cost reductions, or adjacent revenue streams. Upside Foods and Good Meat have regulatory clearance. Aleph Farms and Avant slashed costs by 90% or more. Air Protein and California Cultured diversified beyond traditional meat. Everyone else is struggling.

Investors want proof of customers, not promises. The 2021 funding peak attracted capital based on potential. The 2024 collapse punished companies without traction. SCiFi Foods, backed by Andreessen Horowitz, folded after raising $29M. Industry analysts predict 70 to 90% of current players will fail within a year. The survivors will own the market.

What is cellular agriculture? Cellular agriculture produces animal products (meat, dairy, leather) by culturing cells in bioreactors instead of raising animals. It includes cultivated meat (growing animal cells) and precision fermentation (using microbes to produce proteins).

Which cellular agriculture startup has raised the most funding? Upside Foods leads with $580.8M, followed by The EVERY Company at $246.8M and Eat Just at $220M or more. Upside's funding exceeds the next three competitors combined.

Has any cultivated meat been approved for sale? Yes. Good Meat received approval in Singapore in 2020 and operates commercially. Upside Foods received FDA safety clearance in the US in 2022. Aleph Farms was approved in Israel in 2024.

Why did cellular agriculture funding collapse in 2023? Funding dropped 78% from $807M (2022) to $177M (2023) because investors realized scalability and cost parity would take longer than expected. VCs shifted from funding promises to demanding proof of customers and viable economics.

Which cellular agriculture companies are actually making money? Good Meat is the only company selling cultivated meat commercially. Avant commercialized Zellulin skincare ingredients. California Cultured is preparing a D2C chocolate launch. Most companies remain pre-revenue.

Join 9,000+ founders, investors, and operators. Every week: the deals, the data, and the analysis you won't find anywhere else. Subscribe free

Related Reading: - Top 40 Aquaculture Startups in 2025 - Top 10 Fungi Startups Transforming Materials Food and Medicine in 2025 - Top 20 Sustainable Coffee & Chocolate Startups in 2025